Flowing and falling: Moving from place to place
Thomas Gates, then McNeil's medical director, shot off a memo to the chief executive of Johnson & Johnson, the president of McNeil and other top officials, laying out a detailed "plan of action" for "diffusing media interest" in the research and "limiting the extent and duration of the coverage." Gates envisioned two possibilities: "Low Level of Publicity (most probable scenario)" and "High Level of Publicity (worst case scenario)." For the latter, Gates suggested a series of responses: a letter-writing campaign to medical societies, doctors, pharmacists and academics
People who could previously handle two drinks comfortably often find that one drink produces unexpectedly strong effects while on tirzepatide
Self-experimentation without medical oversight is dangerous with either compound alone
When announcing the authorisation of Mounjaro pens for weight loss management in the UK, the MHRA shared clinical trial results over 16 months showing up to 22.5% weight loss in patients taking Tirzapatide
Molecular Biology of the Cell (Garland Publishing, New York, 2002)